2022
DOI: 10.1002/mp.15458
|View full text |Cite
|
Sign up to set email alerts
|

Knowledge‐based quality control of organ delineations in radiation therapy

Abstract: To reduce the likelihood of errors in organ delineations used for radiotherapy treatment planning, a knowledge-based quality control (KBQC) system, which discriminates between valid and anomalous delineations is developed. Method and Materials:The KBQC is comprised of a group-wise inference system and anomaly detection modules trained using historical priors from 296 locally advanced lung and prostate cancer patient computational tomographies (CTs). The inference system discriminates different organs based on … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
14
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(14 citation statements)
references
References 44 publications
0
14
0
Order By: Relevance
“…In our view, the curated datasets generated in this study have potentially high value for other applications besides DL-based model training. For example, the expert OARs can be used for: 1) benchmarking existing autosegmentation models/solutions against our defined clinical standards; 2) benchmarking clinician/RO OAR segmentation performance across clinical practice; or 3) creating independent H&N OAR QA tools based on feature extraction and machine learningnot forcibly for autosegmentation but rather for verifying OAR consistency on future clinical H&N planning CTs or used as part of an automated watchdog reviewing output of autosegmentation models (8)(9)(10)36). With the H&N datasets generated in this study, we have already done extensive work on example 1 and begun exploratory work on example 3.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In our view, the curated datasets generated in this study have potentially high value for other applications besides DL-based model training. For example, the expert OARs can be used for: 1) benchmarking existing autosegmentation models/solutions against our defined clinical standards; 2) benchmarking clinician/RO OAR segmentation performance across clinical practice; or 3) creating independent H&N OAR QA tools based on feature extraction and machine learningnot forcibly for autosegmentation but rather for verifying OAR consistency on future clinical H&N planning CTs or used as part of an automated watchdog reviewing output of autosegmentation models (8)(9)(10)36). With the H&N datasets generated in this study, we have already done extensive work on example 1 and begun exploratory work on example 3.…”
Section: Discussionmentioning
confidence: 99%
“…Artificial Intelligence (AI) promises to address many persistent RT workflow bottlenecks. In the last 25 years, the RT community has witnessed a renaissance in the evaluation and adoption of machine learning (ML)-based solutions in many aspects of RT patient care, from prognostic methods in the patient outcomes research realm including radiomics, to clinical adoption of platforms for automated or semi-automated RT plan generation and related quality assurance (QA) (1)(2)(3)(4)(5)(6)(7)(8)(9)(10). More recently, we have benefited from a virtual explosion in the application of deep convolutional neural networks (hereafter referred to as deep learning, or DL) for tackling complex imaging-related problems.…”
Section: Introductionmentioning
confidence: 99%
“…It may be possible to link AI algorithms with contour quality assurance using, for example a multi-parametric approach ( 15 , 48 ) or machine learning approach ( 48 ) including sensitivity in Tumor Control Probability (TCP) and Normal Tissue Complication Probability (NTCP) ( 49 ). A recent review article agrees multiple endpoints are needed in assessing contour quality, and clinical validation of meaningful TCP/NTCP endpoints will guide meaningful contour deviations ( 50 ).…”
Section: Discussionmentioning
confidence: 99%
“…Because adapting targets to real‐time changes make clinician approval infeasible, automated QA tools will be needed. Machine learning‐based techniques for detection of erroneous or anomalous delineations 50 or delineation uncertainty maps offer solutions here. 51 , 52 State‐of‐the‐art, online planning assisted with these tools could augment human review in treatment planning and allow smaller treatment margins by reducing inter‐observer variation.…”
Section: Delineationmentioning
confidence: 99%